Literature DB >> 24958707

Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.

Lyticia A Ochola1, Cyrus Ayieko2, Lily Kisia3, Ng'wena G Magak4, Estela Shabani5, Collins Ouma6, Chandy C John7.   

Abstract

Individuals naturally exposed to Plasmodium falciparum lose clinical immunity after a prolonged lack of exposure. P. falciparum antigen-specific cytokine responses have been associated with protection from clinical malaria, but the longevity of P. falciparum antigen-specific cytokine responses in the absence of exposure is not well characterized. A highland area of Kenya with low and unstable malaria transmission provided an opportunity to study this question. The levels of antigen-specific cytokines and chemokines associated in previous studies with protection from clinical malaria (gamma interferon [IFN-γ], interleukin-10 [IL-10], and tumor necrosis factor alpha [TNF-α]), with increased risk of clinical malaria (IL-6), or with pathogenesis of severe disease in malaria (IL-5 and RANTES) were assessed by cytometric bead assay in April 2008, October 2008, and April 2009 in 100 children and adults. During the 1-year study period, none had an episode of clinical P. falciparum malaria. Two patterns of cytokine responses emerged, with some variation by antigen: a decrease at 6 months (IFN-γ and IL-5) or at both 6 and 12 months (IL-10 and TNF-α) or no change over time (IL-6 and RANTES). These findings document that P. falciparum antigen-specific cytokine responses associated in prior studies with protection from malaria (IFN-γ, TNF-α, and IL-10) decrease significantly in the absence of P. falciparum exposure, whereas those associated with increased risk of malaria (IL-6) do not. The study findings provide a strong rationale for future studies of antigen-specific IFN-γ, TNF-α, and IL-10 responses as biomarkers of increased population-level susceptibility to malaria after prolonged lack of P. falciparum exposure.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24958707      PMCID: PMC4187839          DOI: 10.1128/IAI.01924-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Low levels of RANTES are associated with mortality in children with cerebral malaria.

Authors:  Chandy C John; Robert Opika-Opoka; Justus Byarugaba; Richard Idro; Michael J Boivin
Journal:  J Infect Dis       Date:  2006-08-16       Impact factor: 5.226

2.  A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.

Authors:  Anthony W Stowers; Li-how Chen Lh; Yanling Zhang; Michael C Kennedy; Lanling Zou; Lynn Lambert; Timothy J Rice; David C Kaslow; Allan Saul; Carole A Long; Harry Meade; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

3.  Cycles of malaria associated with El Niño in Venezuela.

Authors:  M J Bouma; C Dye
Journal:  JAMA       Date:  1997-12-03       Impact factor: 56.272

4.  Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria.

Authors:  Daniel O Ochiel; Gordon A Awandare; Christopher C Keller; James B Hittner; Peter G Kremsner; J Brice Weinberg; Douglas J Perkins
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1.

Authors:  M Parra; G Hui; A H Johnson; J A Berzofsky; T Roberts; I A Quakyi; D W Taylor
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria.

Authors:  A A Lal; M A Hughes; D A Oliveira; C Nelson; P B Bloland; A J Oloo; W E Hawley; A W Hightower; B L Nahlen; V Udhayakumar
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children.

Authors:  Marthe C D'Ombrain; Leanne J Robinson; Danielle I Stanisic; Jack Taraika; Nicholas Bernard; Pascal Michon; Ivo Mueller; Louis Schofield
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

8.  Malaria modifies neonatal and early-life toll-like receptor cytokine responses.

Authors:  Komi Gbédandé; Stefania Varani; Samad Ibitokou; Parfait Houngbegnon; Sophie Borgella; Odilon Nouatin; Sem Ezinmegnon; Adicatou-Laï Adeothy; Gilles Cottrell; Achille Massougbodji; Kabirou Moutairou; Marita Troye-Blomberg; Philippe Deloron; Nadine Fievet; Adrian J F Luty
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

9.  Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations.

Authors:  Nadya Depinay; Jean Francois Franetich; Anne Charlotte Grüner; Marjorie Mauduit; Jean-Marc Chavatte; Adrian J F Luty; Geert-Jan van Gemert; Robert W Sauerwein; Jean-Michel Siksik; Laurent Hannoun; Dominique Mazier; Georges Snounou; Laurent Rénia
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

10.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.

Authors:  H Bouharoun-Tayoun; C Oeuvray; F Lunel; P Druilhe
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  2 in total

1.  Interferon-γ responses to Plasmodium falciparum vaccine candidate antigens decrease in the absence of malaria transmission.

Authors:  Cyrus Ayieko; Bilha S Ogola; Lyticia Ochola; Gideon A M Ngwena; George Ayodo; James S Hodges; Gregory S Noland; Chandy C John
Journal:  PeerJ       Date:  2017-01-10       Impact factor: 2.984

2.  Changing plasma cytokine, chemokine and growth factor profiles upon differing malaria transmission intensities.

Authors:  Ruth Aguilar; Joseph J Campo; Silvia Chicuecue; Pau Cisteró; Alba Català; Leopoldina Luis; Itziar Ubillos; Beatriz Galatas; Pedro Aide; Caterina Guinovart; Gemma Moncunill; Carlota Dobaño
Journal:  Malar J       Date:  2019-12-05       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.